Page last updated: 2024-08-21
pyrimidine and pd 166326
pyrimidine has been researched along with pd 166326 in 2 studies
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Bornmann, W; Clarkson, B; Hantschel, O; Kuriyan, J; Nagar, B; Scheffzek, K; Superti-Furga, G; Veach, D; Young, MA | 1 |
Sausville, EA | 1 |
Other Studies
2 other study(ies) available for pyrimidine and pd 166326
Article | Year |
---|---|
Structural basis for the autoinhibition of c-Abl tyrosine kinase.
Topics: Benzamides; Catalysis; Crystallography, X-Ray; Enzyme Inhibitors; Imatinib Mesylate; Models, Molecular; Phosphorylation; Piperazines; Protein Binding; Protein Conformation; Proto-Oncogene Proteins c-abl; Pyridines; Pyrimidines; Recombinant Fusion Proteins; src Homology Domains; Structure-Activity Relationship | 2003 |
Is another bcr-abl inhibitor needed for chronic myelogenous leukemia?
Topics: Benzamides; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Piperazines; Pyridines; Pyrimidines | 2003 |